Baylor Genetics’ Chief Medical Officer Dr. Christine Eng explains how RNA sequencing complements DNA testing to unlock diagnoses for rare disease patients.
All in Interview
#383 Inside the Brazilian Rare Genomes Project
How whole genome sequencing is transforming rare disease diagnosis in Brazil featuring MGI’s Victor Camillo and Neogenomica’s Dr. João Bosco Oliveira.
#382 “The Persistence Lab” Episode 1 — Can We Find Cures Faster?
Listen to The Persistence Lab, a new podcast from AbbVie. Hosted by Kira Dineen, the series explores how scientists, patients, and experts look to solve some of the toughest challenges in medicine and health care, one step at a time.
#381 Charles Darwin’s Legacy: What He Got Right & What Science Learned Next
Recorded live at Connecticut’s Darwin Day Event, we examine natural selection, horizontal gene transfer, and how Charles Darwin’s ideas continue to shape genomic science.
#377 Integrating Pharmacogenomics (PGX) into Elder Care
Michele Magner explains how genetics can prevent medication harm in older adults, so people can successfully age in place.
#376 Why Females with Fabry Disease Aren’t “Just Carriers”
Clinical geneticist Dr. Amy Kritzer reveals why Fabry disease looks so different across sexes and what that means for diagnosis and treatment.
#375 How Your Publication Can Fuel Genetic Innovation
Drs. Yuming Hu and Elizabeth Bhoj on bridging research and real-world impact through scientific publishing.
#374 The Eras of Genetic Testing: From the Human Genome Project to Precision Medicine
From early chemotherapy response testing to AI-driven precision medicine, the host of Genetics for Healthcare Rome Madison, shares the evolving eras of genetic testing.
#372 Fighting for Time: Hunter Syndrome, Gene Therapy & Urgent Advocacy
Kristin McKay, Executive Director of Project Alive, is dedicated to accelerating treatments, expanding care, and supporting families affected by Hunter Syndrome, a disease that impacted her brother and now her son.
#371 Growing Old Too Fast: A Mother’s Fight for Cockayne Syndrome Advocacy
Geana Dyer, BS, RN, the Founder of the Cockayne Syndrome Foundation shares her experience parenting 5-year-old Ronin, filmed at the New England Regional Genetics Group (NERGG) conference.
#367 “Gods and Genes”: A Podcast Exploring Science & Spirituality
In the pilot episode of Gene Pool Media’s newest podcast the host Amber Sher, CGC is interviewed about the intersection of genetics, medicine, and faith.
#364 Breast Cancer Genetic Testing in Italy: A Curated Gene Panel
How Italy is integrating cancer genetic testing into its public healthcare system through Negedia’s panels, powered by MGI Tech.
#362 Optical Genome Mapping: Detecting Structural Variants Missed by Traditional Tests
Greenwood Genetics Center’s Dr. Nikhil Sahajpal reveals how OGM is changing clinical diagnostics from missed structural variants to new gene disease association.
#359 Breaking Down Achondroplasia: A Pediatrician in Clinical Genetics Explains
A leading expert in pediatric genetics and skeletal disorders, Dr. Janet Laegare, provides her expertise.
#358 AGBT Precision Health 2025 Meeting Recaps and Reflections
Drs. Christine Eng, Eric Green, and Marina Sirota share highlights of their presentations at this week’s AGBT Precision Health 2025 Meeting in California.
#357 Advice for Science Grad School Applications
Beyond The Thesis with Papa PhD episode where Kira Dineen is interviewed by Dr. David Mendes about science communications, networking, and GC grad school apps.
#355 How Genomics Is Transforming Rare Disease Diagnosis in Turkey
Explore how MGI’s genomic innovation is transforming rare diseases (and even dual diagnoses) care in Turkey and around the globe from Dr. Serdar Ceylaner and Alice Peng.
#354 How Pharmacogenomics is Revolutionizing Drug Prescriptions
Quest Diagnostics' Kristy Bouvier and Kathleen O’Brien explore how pharmacogenetics testing can optimize medications, prevent side effects, and improve treatment.
#353 Advancing Telomere Research: A Breakthrough Leads to Clinical Trial
Live from NYC’s Cocktails & Chromosomes, patient advocate Jena Robertson and researcher Dr. Will Mannherz share personal stories and new breakthroughs bringing telomere biology disorders to a clinical trial this fall.
#352 Why Biotech Will Define the 21st Century
Gene Pool Media’s RealPharma episode features British investor and author Andrew Craig who shares how biotechnology is our future and is being driven by innovations in CRISPR, AI, and genomic science.